This inventor holds 3 USPTO granted patents. Top assignees: Council of Scientific and Industrial Research, Other. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Telangana, IN (2022)
- Hyderabad, IN (2021 - 2024)
Company Filing History:

Years Active: 2021-2024
Title: Innovations by Ummanni Ramesh
Introduction
Ummanni Ramesh is a notable inventor based in Telangana, India. He has made significant contributions to the field of anti-cancer research through his innovative inventions. With a total of 3 patents, Ramesh has focused on developing compounds that have the potential to combat cancer effectively.
Latest Patents
One of his latest patents is titled "Nimbolide analogs as anti-cancer agents and preparation thereof." This invention relates to nimbolide analogs that are useful as anti-cancer agents. The invention particularly focuses on nimbolide analogs of a general formula, where various rings and groups are selected to enhance their efficacy.
Another significant patent is "Spirooxindole compounds as GSK3B inhibitors and process for preparation thereof." This invention provides a compound of a general formula that serves as GSK3β inhibitors, showcasing their anticancer potential and detailing the process for preparing these spirooxindoles.
Career Highlights
Ummanni Ramesh has worked with the Council of Scientific and Industrial Research, contributing to various research initiatives. His work has been instrumental in advancing the understanding of cancer treatment through innovative chemical compounds.
Collaborations
Ramesh has collaborated with notable individuals in his field, including Srivari Chandrasekhar and Prathama Satyendra Mainkar. These collaborations have further enriched his research and development efforts.
Conclusion
Ummanni Ramesh's contributions to cancer research through his patents highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile